Detalles de la búsqueda
1.
Standardization of a flow cytometry SARS-CoV-2 serologic test
Preprint
en Inglés
| PREPRINT-MEDRXIV | ID: ppmedrxiv-21250770
2.
Cohort profile: A Quebec-based plasma donor biobank to study COVID-19 immunity (PlasCoV)
Preprint
en Inglés
| PREPRINT-MEDRXIV | ID: ppmedrxiv-22282156
3.
Antibody binding to SARS-CoV-2 S glycoprotein correlates with, but does not predict neutralization
Preprint
en Inglés
| PREPRINT-BIORXIV | ID: ppbiorxiv-287482
4.
Development and use of a method based on the anti-N reactivity of longitudinal samples to better estimate SARS-CoV-2 seroprevalence in a vaccinated population
Preprint
en Inglés
| PREPRINT-MEDRXIV | ID: ppmedrxiv-22278798
5.
High-throughput detection of antibodies targeting the SARS-CoV-2 Spike in longitudinal convalescent plasma samples
Preprint
en Inglés
| PREPRINT-BIORXIV | ID: ppbiorxiv-346783
6.
Longitudinal analysis of the humoral response to SARS-CoV-2 spike RBD in convalescent plasma donors
Preprint
en Inglés
| PREPRINT-BIORXIV | ID: ppbiorxiv-206847
7.
The Fc-effector function of COVID-19 convalescent plasma contributes to SARS-CoV-2 treatment efficacy in mice
Preprint
en Inglés
| PREPRINT-BIORXIV | ID: ppbiorxiv-495677
8.
Decline of humoral responses against SARS-CoV-2 Spike in convalescent individuals
Preprint
en Inglés
| PREPRINT-BIORXIV | ID: ppbiorxiv-194639
9.
Humoral responses against BQ.1.1 elicited after breakthrough infection and SARS-CoV-2 mRNA vaccination
Preprint
en Inglés
| PREPRINT-MEDRXIV | ID: ppmedrxiv-22283723
10.
SARS-CoV-2 BA.4/5 Spike recognition and neutralization elicited after the third dose of mRNA vaccine
Preprint
en Inglés
| PREPRINT-MEDRXIV | ID: ppmedrxiv-22278386
11.
Humoral immune responses against SARS-CoV-2 Spike variants after mRNA vaccination in solid organ transplant recipients
Preprint
en Inglés
| PREPRINT-MEDRXIV | ID: ppmedrxiv-22275056
12.
Longitudinal analysis of humoral immunity against SARS-CoV-2 Spike in convalescent individuals up to 8 months post-symptom onset
Preprint
en Inglés
| PREPRINT-BIORXIV | ID: ppbiorxiv-428097
13.
Major role of IgM in the neutralizing activity of convalescent plasma against SARS-CoV-2
Preprint
en Inglés
| PREPRINT-BIORXIV | ID: ppbiorxiv-333278
14.
Evaluation of a Commercial Culture-free Neutralization Antibody Detection Kit for Severe Acute Respiratory Syndrome-Related Coronavirus-2 and Comparison with an Anti-RBD ELISA Assay
Preprint
en Inglés
| PREPRINT-MEDRXIV | ID: ppmedrxiv-21250325
15.
Convalescent plasma for hospitalized patients with COVID-19 and the effect of plasma antibodies: a randomized controlled, open-label trial
Preprint
en Inglés
| PREPRINT-MEDRXIV | ID: ppmedrxiv-21259427
16.
A boost with SARS-CoV-2 BNT162b2 mRNA vaccine elicits strong humoral responses independently of the interval between the first two doses
Preprint
en Inglés
| PREPRINT-MEDRXIV | ID: ppmedrxiv-22273967
17.
Strong humoral immune responses against SARS-CoV-2 Spike after BNT162b2 mRNA vaccination with a sixteen-week interval between doses
Preprint
en Inglés
| PREPRINT-MEDRXIV | ID: ppmedrxiv-21263532
18.
Cross-sectional evaluation of humoral responses against SARS-CoV-2 Spike
Preprint
en Inglés
| PREPRINT-BIORXIV | ID: ppbiorxiv-140244
19.
SARS-CoV-2 Omicron Spike recognition by plasma from individuals receiving BNT162b2 mRNA vaccination with a 16-weeks interval between doses
Preprint
en Inglés
| PREPRINT-BIORXIV | ID: ppbiorxiv-473679
Resultados
1 -
19
de 19
1
Próxima >
>>